The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Exciting updates in CLL and the importance of immune characterization
Clare Sun, MD, National Institutes of Health, Bethseda, MD, shares some insights into exciting treatment updates in chronic lymphocytic leukemia (CLL), drawing focus on the promise of combination approaches, and further highlights the importance of immune characterization in patients. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research funding: Genmab
